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Introduction {#sec1}
============

Lymphocytes survey antigen by circulating through blood, lymph nodes (LNs) and lymph and shape specific immune responses in LNs. To enter LNs, lymphocytes must undergo extensive interactions with high endothelial cell venules (HEVs) ([@bib5], [@bib11], [@bib21], [@bib31], [@bib40], [@bib42], [@bib43], [@bib44]). Lymphocytes initially tether on peripheral nodal addressin (PNAd) expressed on HEVs using L-selectin (CD62L) as a ligand. Lymphocytes roll along the vascular endothelium and become activated via interactions of the chemokine receptors CCR7 and CXCR4 with their respective ligands CCL21 and CXCL12. Activated leukocytes use the integrin LFA-1 (CD11a) to bind to ICAM-1 to promote adhesion and finally emigrate into the LN parenchyma.

After LN entry, lymphocytes interact with dendritic cells in order to scan presented antigen ([@bib13]), and finally emigrate into efferent lymphatic vessels. For this egress, expression of the sphingosine-1-phosphate-receptor 1 (S1P1, encoded by *S1pr1*) on lymphocytes is critical, recognizing the chemoattractant phospholipid sphingosine-1-phosphate (S1P) ([@bib27]). S1P concentrations are high in blood and lymph but low in tissues, thus providing a gradient that guides lymphocytes out of the LN and into efferent lymph ([@bib7]). This mechanism is therapeutically exploited for treating multiple sclerosis patients by antagonizing S1P1 function with the drug FTY720 (fingolimod) to keep autoreactive T cells from exiting LNs and entering the central nervous system ([@bib26]).

Lymphocyte trafficking into LNs is believed to occur in a continuous fashion, and not to be influenced by time-of-day variables. Moreover, it is generally unclear whether circadian rhythms regulate overall cellularity in these tissues ([@bib1], [@bib9], [@bib12], [@bib17]).

Circadian rhythms are important drivers for most physiological processes as they align the body with rhythmically occurring daily changes in the environment ([@bib8]). They normally rely on an intricate interplay of cell-intrinsic clock genes driving circadian responses ([@bib29]). Daily oscillations of lymphocyte counts in blood have been described ([@bib2], [@bib6], [@bib16], [@bib20], [@bib36]) and cells of the adaptive immune system such as T and B cells, as well as dendritic cells, possess the components of the molecular clock machinery ([@bib3], [@bib17], [@bib38]). In contrast to monocytes of the innate immune system ([@bib32]), however, the functional relevance of these cell-intrinsic oscillations for lymphocytes is unclear ([@bib17]). Stimulated by previous findings, which described periodic oscillations in innate immune cell function ([@bib14], [@bib32], [@bib35]) and T helper-17 (Th17) cell differentiation ([@bib45]), we postulated that the migration of lymphocytes through murine LNs might be regulated in a circadian manner with direct relevance for the mounting of adaptive immune responses.

Results {#sec2}
=======

Lymphocyte Numbers Exhibit Circadian Oscillations in Lymph Nodes {#sec2.1}
----------------------------------------------------------------

In contrast to circulating blood lymphocyte numbers, which peak during the day in mice around *Zeitgeber* time (ZT) 5 (i.e., 5 hr after light onset) ([Figure 1](#fig1){ref-type="fig"}A), numbers for CD4^+^ and CD8^+^ T cells as well as B cells showed delayed oscillations (by ∼8 hr) in inguinal lymph nodes (iLNs), with highest counts occurring at the beginning of the dark phase (ZT13, i.e., 1 hr after lights off) ([Figure 1](#fig1){ref-type="fig"}A). These rhythms were consistently observed for naive and central memory T cells, demonstrating a broad phenomenon also affecting T lymphocyte subpopulations ([Figures S1](#mmc1){ref-type="supplementary-material"}A--S1C). Oscillations were not only observed in the rhythmic environment represented by 12 hr light:12 hr dark conditions (LD) but were sustained in constant darkness (dark:dark, DD), indicating their bona fide endogenous circadian nature ([Figure 1](#fig1){ref-type="fig"}B). Light exposure was an important entrainment factor, since rhythms were inverted when the light regime was reversed (DL) ([Figure 1](#fig1){ref-type="fig"}B). Rhythms were furthermore detected across various types of LNs ([Figure 1](#fig1){ref-type="fig"}C and [Figures S1](#mmc1){ref-type="supplementary-material"}D--S1F), indicating a relevant phenomenon across the LN compartment. To investigate the underlying mechanisms driving these oscillations, we focused on the cellular LN input and output pathways by blocking lymphocyte homing or egress, both critical determinants of LN cellularity ([@bib22]). Blocking homing with anti-integrin antibodies dramatically decreased LN cellularity over 24 hr while blocking lymphocyte egress with FTY720 increased LN cellularity over the same time frame, confirming the temporally highly dynamic cellular nature of this tissue ([Figures 1](#fig1){ref-type="fig"}D and 1E). Both treatments ablated rhythmicity, indicating that lymphocyte homing and egress---but not intranodal proliferation ([Figures S1](#mmc1){ref-type="supplementary-material"}G and S1H)---were the central determinants of circadian oscillatory cellularity. These data demonstrate a striking circadian oscillation in lymph node cellularity, peaking at night onset.

Lymphocyte Homing Is Dependent on Oscillations in Lymphocytes and Microenvironment {#sec2.2}
----------------------------------------------------------------------------------

We next used adoptive transfer techniques to determine whether lymphocyte homing to the LN was occurring in a rhythmic manner. LN infiltration of lymphocyte subpopulations peaked around night onset and remained low during the day ([Figure 2](#fig2){ref-type="fig"}A). To define whether oscillations were determined by lymphocyte-intrinsic and/or microenvironmental signals, we adoptively transferred cells harvested at ZT5 ("day") or ZT13 ("night") into LD-entrained recipients at either ZT5 or ZT13. While "day" (cells) into "day" (recipient) transfers exhibited the lowest homing capacity and "night" into "night" transfers the highest, a mixed contribution of both lymphocyte and microenvironment timing was observed in the "day" into "night" and "night" into "day" chimeras ([Figure 2](#fig2){ref-type="fig"}B). A screen for oscillations of promigratory factors on T and B cells revealed that expression of the chemokine receptor CCR7 exhibited rhythmicity peaking at ZT13 ([Figure 2](#fig2){ref-type="fig"}C) while the adhesion molecules CXCR4, CD11a, and L-selectin showed either no oscillations or not for all lymphocyte subpopulations ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). In addition, expression analyses of whole lymph node mRNA and extracellular protein on HEVs revealed oscillatory amounts of the chemokine CCL21, a ligand for CCR7---but not CXCL12 (not shown)---being high around night onset ([Figures 2](#fig2){ref-type="fig"}D and 2E). HEVs also exhibited rhythmic expression of ICAM-1 but not of PNAd ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). Oscillations in lymphocyte chemokine receptors were critical for rhythmic homing because a titrated, short pretreatment of adoptively transferred cells with pertussis toxin (PTX) ([@bib22]), an inhibitor of chemokine receptor signaling, ablated rhythmicity ([Figure 2](#fig2){ref-type="fig"}F). To investigate the involvement of CCR7 in this process, we analyzed total lymph node cellularity of CCR7-deficient mice, as well as the rhythmic homing capacity of isolated CCR7-deficient cells. *Ccr7*^*−/−*^ mice exhibited no oscillations in lymph node cell counts while also exhibiting the expected lower overall numbers ([@bib10]) ([Figure 2](#fig2){ref-type="fig"}G). In addition, *Ccr7*^*−/−*^ cells failed to show rhythmic lymph node homing ([Figure 2](#fig2){ref-type="fig"}H). These data demonstrated that lymphocyte recruitment to LNs is determined by rhythms in leukocytes and the microenvironment, along with in-phase expression of the CCR7-CCL21 receptor-ligand axis.

Circadian Clocks Control Cellular Oscillations in Lymph Nodes {#sec2.3}
-------------------------------------------------------------

LNs exhibit oscillations of clock genes ([Figure 3](#fig3){ref-type="fig"}A), prompting us to investigate the role of lymphocyte clocks in their migratory behavior. We generated mice in which the core clock gene *Bmal1* (also known as *Arntl*) was deleted in T cells (*Bmal1*^*flox/flox*^x*Cd4-cre*) or B cells (*Bmal1*^*flox/flox*^x*Cd19-cre*) ([Figure 3](#fig3){ref-type="fig"}B and [Figures S2](#mmc1){ref-type="supplementary-material"}E and S2F). Remarkably, loss of lymphocyte BMAL1 ablated the overall rhythmicity of T and B cell numbers in lymph nodes ([Figure 3](#fig3){ref-type="fig"}C and [Figure S2](#mmc1){ref-type="supplementary-material"}G). In addition, rhythmic homing of *Bmal1*^*flox/flox*^x*Cd4-cre* T cells into WT recipients was ablated ([Figure 3](#fig3){ref-type="fig"}D). In agreement with these findings, rhythmic expression of CCR7 surface protein ([Figure 3](#fig3){ref-type="fig"}E) and mRNA ([Figure 3](#fig3){ref-type="fig"}F) was absent in BMAL1-deficient CD4^+^ T cells, indicating the regulation of the molecule at the transcriptional level by the circadian clock. Together, these data provide evidence for a functional role of cell-autonomous clocks in lymphocyte migration.

Lymphatic Egress from Lymph Nodes Is under Circadian Control {#sec2.4}
------------------------------------------------------------

Because our data indicated that, in addition to a rhythmic homing component, lymphocyte egress might counterbalance LN oscillations ([Figures 1](#fig1){ref-type="fig"}D and 1E), we quantified lymphocyte numbers in lymph fluid by cannulating efferent lymphatic vessels. Prominent rhythms in cellular counts were detected, peaking at ZT9 and exhibiting a low at ZT21 ([Figure 4](#fig4){ref-type="fig"}A). These oscillations were observed for different lymphocyte populations ([Figure 4](#fig4){ref-type="fig"}A and [Figures S2](#mmc1){ref-type="supplementary-material"}H and S2I) and were bona fide circadian in nature as they persisted in constant darkness ([Figure 4](#fig4){ref-type="fig"}B). Rhythms were not due to higher lymph volume or flow rates at different times of the day ([Figure S2](#mmc1){ref-type="supplementary-material"}J). To verify whether oscillations in lymph cellularity were truly attributable to rhythmic egress and not secondary to rhythmic input into LNs ([Figure 2](#fig2){ref-type="fig"}A), we transferred lymphocytes at different times of the day, blocked subsequent LN entry and quantified their transit through the LN into lymph over time ([@bib25]). A higher LN retention capacity of cells injected at ZT13 was observed compared to ZT5 and a less rapid accumulation of cells in lymph ([Figures 4](#fig4){ref-type="fig"}C and 4D and [Figure S3](#mmc1){ref-type="supplementary-material"}), demonstrating lymphocyte egress to be highly rhythmic. This effect resulted in longer LN half-lives of cells injected at ZT13 (CD4: 12 hr, CD8: 12 hr, B cells: 16 hr) compared to ZT5 (CD4: 9 hr, CD8: 9 hr, B cells: 13.5 hr) ([Figures 4](#fig4){ref-type="fig"}C and 4D and [Figure S3](#mmc1){ref-type="supplementary-material"}). T- and B cell-specific BMAL1-deletion ablated oscillations in lymph, indicating the importance of cell-autonomous clocks also for lymphocyte egress ([Figure 4](#fig4){ref-type="fig"}E and data not shown). Of importance, adoptively transferred BMAL1-deficient CD4^+^ T cells exhibited no time-of-day variations in their LN half-life ([Figure 4](#fig4){ref-type="fig"}F), demonstrating the relevance of T cell clocks in their rhythmic trafficking behavior.

Using a mathematical approach, we assessed whether oscillatory LN counts could be modeled with only either homing or egress to be rhythmic or whether both components needed to oscillate. Although oscillations were also observed when only one component was rhythmic, the best fit was achieved when both homing and egress were assumed to oscillate, thus supporting our experimental data ([Figure 4](#fig4){ref-type="fig"}G and [Figure S4](#mmc1){ref-type="supplementary-material"}). In summary, lymphocyte clocks and the time-of-day entry of cells into LNs have functional consequences for LN transit and egress into lymph.

Rhythmic Lymphocyte Egress Depends on Oscillatory *S1pr1* Expression {#sec2.5}
--------------------------------------------------------------------

S1P-receptors are critical in regulating lymph node egress ([@bib7]). We therefore investigated whether expression of S1P-receptor family members exhibited oscillations using quantitative PCR (Q-PCR). All S1P receptors exhibited robust diurnal oscillations peaking between ZT1 and ZT9 ([Figure 5](#fig5){ref-type="fig"}A and [Figure S5](#mmc1){ref-type="supplementary-material"}A), which coincided with high lymphocyte egress. In addition, FTY720, as well as the S1P1-specific functional antagonist SEW2871 strongly down-modulated lymphatic egress in a time- and concentration-dependent manner ([Figures 5](#fig5){ref-type="fig"}B and 5C and [Figure S5](#mmc1){ref-type="supplementary-material"}B). The observation that FTY720-treated animals exhibited reduced but still rhythmic lymph cellularity indicated a daytime-sensitive role for S1P1 in mediating lymphocyte exit. Rhythmic expression of *S1pr1* was ablated in BMAL1-deficient CD4^+^ T cells, pointing toward a regulation of the gene by the circadian clock ([Figure 5](#fig5){ref-type="fig"}D). To investigate this in more detail, we performed an in vitro assay, in which the promoter region of *S1pr1* was cloned in front of the luciferase (*luc*) reporter gene. Luciferase activity in HEK293 cells transfected with the *S1pr1-luc* reporter was decreased after co-transfection of increasing amounts of *Bmal1* and *Clock* expression plasmids ([Figure 5](#fig5){ref-type="fig"}E). This demonstrated that expression of *S1pr1* is regulated by BMAL1 and CLOCK.

To confirm the role of S1P1 in the time-of-day-dependent egress genetically, we generated T cell-specific mice that were heterozygous for *S1pr1* in order not to completely block lymphocyte egress ([@bib27]) but to titrate S1P1 amounts, as loss of one allele had been demonstrated to result in haploinsufficiency ([@bib22]). *S1pr1*^*+/flox*^*xCd4-cre* mice exhibited no more oscillations in LN counts and altered lymph rhythmicity, demonstrating the importance of S1P1 in the proper timing of lymphocyte egress ([Figures 5](#fig5){ref-type="fig"}F and 5G and [Figure S5](#mmc1){ref-type="supplementary-material"}C). Importantly, no diurnal oscillations were observed in amounts of S1P in efferent lymph ([Figure 5](#fig5){ref-type="fig"}H) or in S1P synthesizing or degrading enzymes in lymph node ([Figure S5](#mmc1){ref-type="supplementary-material"}D), suggesting that oscillatory expression of the receptor (S1P1) and not its ligand (S1P) was the driver for rhythmic lymphocyte egress. Together, these data demonstrate a critical role for S1P1 in mediating circadian lymphocyte egress from lymph nodes into efferent lymph.

Relevance of Circadian Oscillations in Lymph Node Cellularity {#sec2.6}
-------------------------------------------------------------

We hypothesized that oscillatory lymphocyte counts in LNs might have functional consequences in a potential time-of-day dependence of adaptive immune responses. We therefore tested whether the activation status of lymphocytes in LNs varied over the course of the day. More activated T cells were present in LNs at night onset as assessed by CD69 staining, coinciding with higher overall lymphocyte counts at this time ([Figure 6](#fig6){ref-type="fig"}A). Because dendritic cells (DCs) are key antigen-presenting cells critical in the activation of lymphocytes and the generation of adaptive immune responses ([@bib15]), we next investigated whether these cells also exhibited oscillatory LN counts. Migratory DC cellularity showed strong oscillations peaking in phase with lymphocytes ([Figure 6](#fig6){ref-type="fig"}B and [Figure S6](#mmc1){ref-type="supplementary-material"}A). These data point to the existence of a concerted circadian migration pattern of antigen-bearing (DCs) and antigen-recognizing (T cells) cells in LNs.

Recent evidence indicates that the immune system can respond to challenges in a rhythmic fashion ([@bib12], [@bib14], [@bib32], [@bib35], [@bib39]). We therefore investigated the pathophysiological significance of circadian oscillatory LN counts in the autoimmunity model of EAE. Mice immunized during the late light phase (ZT8, when cell counts are high in LNs, [Figures 1](#fig1){ref-type="fig"}A and 1C) showed a dramatically accelerated disease progression 2 weeks later, with higher clinical scores compared to late night-immunized animals (ZT20, when LN counts trough) ([Figure 6](#fig6){ref-type="fig"}C). Differences in disease scores were associated with higher immune cell infiltration and demyelination in the spinal cord at the peak of the disease ([Figures 6](#fig6){ref-type="fig"}D and 6E). We detected elevated interleukin-2 (*Il2*) mRNA amounts ([Figure 6](#fig6){ref-type="fig"}F) and a higher number of IL-17 producing as well as very-late antigen (VLA)-4 integrin positive CD4^+^ T cells in LNs of ZT8-immunized mice, subtypes that have been shown to be critical for the induction of EAE ([@bib18]) ([Figure 6](#fig6){ref-type="fig"}G). This indicated that circadian regulation of immunization occurred at a very early phase of the process when T cells are activated in draining lymph nodes ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Two days after induction of EAE, an increase of both naive and activated CD4^+^ and CD8^+^ T cells was detected in draining lymph nodes of ZT8-immunized animals, while in ZT20-immunized animals T cell numbers remained relatively low ([Figures 6](#fig6){ref-type="fig"}H--6J and [Figure S6](#mmc1){ref-type="supplementary-material"}C). Thus, oscillations in the numbers of CD4^+^ T cells in lymph nodes during initial encounter with antigen appear to be pivotal for the severity of EAE. To investigate whether T cell autonomous clocks regulate this response, we genetically deleted T cell circadian clock function. Although in control animals disease development depended on the time of immunization, in T cell specific *Bmal1*^*−/−*^ mice it did not ([Figure 6](#fig6){ref-type="fig"}K). Two days after immunization, total and T cell counts in draining lymph nodes were different at ZT15 between day- and night-immunized control, but not in T cell specific *Bmal1*^*−/−*^ mice ([Figure 6](#fig6){ref-type="fig"}L and [Figure S6](#mmc1){ref-type="supplementary-material"}D). Hence, T cell clocks determine time-of-day function and, after challenge, development of autoimmune sequelae. We finally investigated whether adaptive immune responses to pathogens exhibited similar circadian rhythmicity. Mice were infected with the gastric bacterial pathogen *Helicobacter pylori* at three different time points during the day, and lymph node counts were quantified 3 weeks later. Also in this chronic infection model, LN counts showed strong circadian responsiveness to the initial infection with highest numbers present at ZT7, analogous to the EAE immunization experiments ([Figure S6](#mmc1){ref-type="supplementary-material"}E). In addition, acute viral infection with influenza A virus led to stronger pulmonary infiltration of CD8^+^IFN-γ^+^ T cells when animals were infected at ZT8 compared to ZT20, 8 days post infection ([Figure S6](#mmc1){ref-type="supplementary-material"}F). Together, these data strongly indicate that immunization reactions and the adaptive immune responses to various pathogens follow a circadian rhythm ([Figure 6](#fig6){ref-type="fig"}M and [Movie S1](#mmc2){ref-type="supplementary-material"}).

Discussion {#sec3}
==========

We have described here the mechanisms that govern a circadian rhythmicity in the capacity of lymphocytes to enter and exit lymph nodes, which depend on cell-autonomous, clock-gene-controlled expression of promigratory factors. Lymphocytes entered LNs most prominently at the onset of the night phase and egressed from the tissue during the day. This resulted in oscillatory cell counts in lymph nodes and lymph and time-of-day differences in the adaptive immune response weeks after immunization. In addition, DCs were found to be present in LN in highest numbers around night onset, peaking in phase with the lymphocyte populations. Our data reveal that T cell-autonomous circadian oscillations are critical in regulating adaptive immunity.

It is surprising to note that lymph nodes exhibit circadian differences in their cellularity, given that they represent such a central tissue of the immune system and, accordingly, have thus been intensely studied. Since we observed oscillations in all investigated lymph nodes, the phenomenon appears to be broad and robust and not restricted to specific body locations. It is noteworthy that other lymphoid organs such as the thymus (data not shown) and the bone marrow do not exhibit overt circadian oscillations in absolute numbers. At least the latter, however, still displays circadian activity in cellular trafficking as hematopoietic stem and progenitor cells (HSPCs) are mobilized into blood ([@bib24], [@bib28]) and recruited back into the bone marrow ([@bib35]) at different times. The fraction of mobilized and homed cells might be small compared with the overall numbers, though, which might explain why overt oscillations of total cells in the BM are not observed. In contrast to the BM, lymph node total cellularity is highly dynamic over 24 hr, as seen when homing or egress is blocked. Still, homing of leukocytes to lymph nodes and bone marrow occurs predominantly at night, while egress (or mobilization in the case of the bone marrow) occurs predominantly during the day. Thus, rhythmic egress of lymphocytes via efferent lymph is a major mechanism underlying the oscillatory leukocyte numbers in blood. Whether other egress routes for lymphocytes, from the thymus or the spleen, occur in a circadian manner is currently unclear.

Our data point to a critical role of cell-intrinsic clock-dependent mechanisms in the regulation of T and B lymphocyte trafficking. While global BMAL1 deficiency results in a diverse array of phenotypes ([@bib4]), such as altered B cell numbers ([@bib41]), few studies have focused on cell-type specific deletion of BMAL1 in the immune system. Lineage-specific ablation of BMAL1 in myeloid cells results in a pro-inflammatory state ([@bib32]), yet a similar approach targeting lymphocytes yielded no obvious phenotype ([@bib17]). The latter finding might be due to mice with clock-deficient lymphocytes exhibiting phenotypes only at specific times, so that only when tested over multiple time points across the day can alterations be detected. Our data showing that lack of BMAL1 in T cells ablated oscillations in EAE disease scores indicates an important role for T cell clocks in the adaptive immune response. This is in line with a previous observation that T cells harvested from *Clock* mutant mice exhibited altered proliferation responses at specific times ([@bib12]).

We demonstrated the critical regulators of lymphocyte trafficking, *Ccr7* and *S1pr1*, to be under circadian control. *Ccr7* and *S1pr1* oscillations showed opposite phases, being high in the evening for the former and high during the day for the latter. This agrees with the additional role of CCR7 as a retention factor for T cells in lymph nodes that can antagonize S1P1 function ([@bib33]). In addition, more T cells expressed the activation marker CD69 at night onset, a negative regulator of S1P1 ([@bib37]). These inverted oscillations of retention and egress factors appeared to be responsible for keeping lymphocytes retained in the node at night and promoting daytime egress. In addition to these lymphocyte intrinsic signals, the microenvironmental fluctuation of CCL21 indicated an additional rhythmic component that was non cell-autonomous. Whether direct autonomic innervation governs these oscillations---as has been shown for the bone marrow and skeletal muscle ([@bib28], [@bib35])---and/or humoral factors as has been shown for the lung ([@bib14]), is outside the scope of this manuscript and should be investigated in the future.

Lymph nodes act as the body's immunological sieve, capturing lymph-borne antigens and antigen-presenting cells (APCs) and bringing these components in close contact with lymphocytes. Our data show that not only T cells migrate to the lymph node in a circadian manner but that also dendritic cells, the major APCs, are present more prominently around night onset, peaking at the same time as lymphocytes. Both cell types need to interact to produce a functional adaptive immune response ([@bib13]). It therefore appears likely that having them present at the same time in the confined environment of the lymph node enhances the likelihood of antigen encounter by the very few specific T cell clones, as opposed to cells entering and exiting at random times. This process of more effective cellular interactions appears to be further helped by the fact that during the night fewer cells exit the tissue than during the day, thus giving APC-T cell pairs more time to interact functionally. Whether also antigen encounter with APCs at peripheral surfaces is occurring in a rhythmic manner, which could ultimately be driving a circadian migratory DC process, should be the subject of future investigations.

Compared to the immediate response of the innate immune system, which is under circadian control ([@bib14], [@bib19], [@bib32], [@bib35]), it is remarkable that also the adaptive immune system appears to be temporally regulated, because these responses take much longer to be mounted. How can the time-of-day dependent differences encountered during the initial stimulus be preserved to exhibit circadian gating of immune responses weeks later? It appears that the initial hours in the generation of the adaptive immune response and the number of cells present in the lymph node are critical in regulating the strength of the response ([@bib30]), which cannot be compensated for by the next circadian cycle.

In steady state, critical factors of the immune system oscillate in mice and humans with opposite phases according to their inverted rest-activity times ([@bib2], [@bib6], [@bib20], [@bib36]). Circulating leukocyte counts are high during the respective resting phases, which occur during the day in mice and at night in humans. In addition, also under stimulated conditions timing matters, as administration of granulocyte colony-stimulating factor (G-CSF) to patients in order to mobilize hematopoietic stem cells from bone marrow into blood yields higher numbers at different times than in mice ([@bib24]). These data suggest that also adaptive immune responses in humans could be under circadian control. Since in our EAE model, immunization close to the onset of the activity phase produced a higher immune response in mice, in humans the early morning hours should produce a higher adaptive immune reactivity. Indeed, this appears to be the case as recent studies have unveiled that administration of hepatitis A ([@bib34]) and flu vaccines ([@bib23]) in the morning yielded highest antibody titers compared to other times. Together, our data provide mechanistic insights for a time-of-day difference in lymphocyte trafficking and adaptive immune responses, thus warranting further investigations into time-of-day optimization of immune therapies and vaccination programs.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

*Cd4cre*, *Lckcre*, *Cd19cre*, *Bmal1*^*flox/flox*^, and *S1pr1*^*flox/flox*^ mice were obtained from Jackson Laboratories and crossbred to target T cells and B cells, respectively. *Ccr7*^−/−^ mice were a gift from Reinhold Förster. 7- to 8-week-old wild-type C57BL/6 mice were purchased from Charles River and Janvier. Mice were housed under a 12 hr:12 hr light-dark cycle with food and water ad libitum. To induce changes in light regime, we placed mice in a light cycler (Park Bioservices) with a 12 hr-inverted light cycle for a minimum of 2 weeks to completely establish an inverse light cycle or kept in constant darkness. All animal experimental procedures were carried out in accordance with the German Law of Animal Welfare and approved by the Regierung of Oberbayern or the ethics committee of the Schleswig-Holstein State Ministry of Energy, Agriculture, Environment and Rural Areas.

Flow Cytometry {#sec4.2}
--------------

Blood was collected into EDTA-coated capillary tubes (Microvete 300). Counts were obtained using an IDEXX ProCyte DX cell counter or a Hemavet Hematology Analyzer 950FS (Drew Scientific). Erythrocytes were lysed by incubation in 0.8% NH~4~Cl. Lymph was collected as described below. Spleens, lymph nodes, or thymi were harvested from animals and processed through a cell strainer (40--70 μM pore size) and resuspended in PBS. For quantification of dendritic cells, lymph nodes were first chopped into small pieces and incubated in collagenase IV (1 mg/ml, C5138, Sigma) and DNase I (0.2 mg/ml, Roche) for 30 min at 37°C with gentle agitation. Following digestion, cells were passed through a 40 μm strainer and resuspended in PBS supplemented with 2% fetal bovine serum (GIBCO). A 20 min blocking step using anti-CD16/32 antibody (2.4G2; BD Biosciences) was performed on ice prior to fluorescent staining. Single-cell suspensions were stained with fluorescence-conjugated antibodies and analyzed by flow cytometry using a Gallios Flow Cytometer (Beckman Coulter) or a FACSCanto II flow cytometer (BD Biosciences). Prior to staining of intracellular cytokines, cells were restimulated for 5 hr with PMA and ionomycine (cell stimulation cocktail with protein transport inhibitors, eBioscience). Data were analyzed with FlowJo software (Tree Star).

Adoptive Transfer Studies {#sec4.3}
-------------------------

Lymphocytes from spleen and peripheral lymph nodes (ratio 80:20) were labeled with 1.5 μM of carboxyfluorescein succinimidyl ester (CFSE, Thermo Fisher Scientific) or 2.5 μM CellTracker Red CMTPX (Thermo Fisher Scientific) in PBS containing 0.2% BSA and 2 mM EDTA for 20 min at 37°C and washed 4 times. 20 × 10^6^ cells were then injected i.v. into recipient mice. In some experiments, lymph node entry was blocked two and 12 hr later by intraperitoneal (i.p.) administration of 100 μg anti-α~L~ (CD11a, clone M17/4; BioXCell) and anti-α~4~ (CD49d, clone PS/2; BioXCell) integrin antibodies in PBS. In some experiments, cells were pre-incubated with a 200 ng/ml pertussis toxin (PTX) pulse of 10 min at 37°C and washed 4 times before injection together with control-treated cells ([@bib22]). The subsets of adoptively transferred cells in the recipient mice were analyzed via flow cytometry. Dyes were switched to avoid dye-specific effects.

*S1pr1* Promoter Luciferase Reporter Assay {#sec4.4}
------------------------------------------

The *S1pr1-*Gaussia Luciferase (*S1pr1*-GLuc) GLuc-ON promoter clone containing a ∼1 kb fragment upstream of the transcription start site and a ∼0.3 kb fragment of the exon 1 of murine *S1pr1* in pEZX-PG04 vector (also containing a constitutively expressed secreted alkaline phosphatase (SEAP) secondary reporter as an internal control) was obtained from GeneCopoeia. HEK293AAV cells (Cellbiolabs) were plated onto 96-well plates and maintained in DMEM with 2 mM stable glutamine supplemented with 10% fetal bovine serum (FBS) and 10,000 U penicillin/streptomycin at 37°C with 5% CO2. Upon 80%--90% confluence, cells were transfected with the following expression plasmids: 20 ng *S1pr1-luc* with various combinations of the following clock gene constructs: *HA-Clock*, *HA-Bmal1*, and *pcDNA3.1* (mock transfection) as indicated per well using Lipofectamine 3000 transfection reagent (Thermo Fisher Scientific) according to the manufacturer's protocol. Medium was changed once on the next day and was collected for measurement 48 hr after transfection. The secreted GLuc and SEAP activities were measured with the Secrete-Pair Dual Luminescence Assay Kit (GeneCopoeia) according to the manufacturer's protocol using the Berthold TriStar LB 941 plate reader (Berthold Technologies). Normalized promoter activity was calculated as the ratio of GLuc to SEAP activities.

Lymph Cannulation {#sec4.5}
-----------------

40 min prior to cannulation, 200 μl olive oil was administered intragastrally to identify mesenteric lymph vessels that are located just upstream of the thoracic duct. Mice were anesthetized (100 mg/kg ketamine, 20 mg/kg xylazine, 1% acepromazin i.p.), vessels were cannulated and lymph was drawn via a fine bore polythene tubing (Smiths Medical) that had previously been flushed with PBS containing EDTA. In some experiments, mice were injected i.p. with 1 mg/kg (or less) of FTY720 or 10 mg/kg of SEW2871 1 or 2 hours, respectively, before cannulation. Cell numbers were determined using an IDEXX ProCyte DX cell counter.

Immunofluorescence Microscopy and Quantitative Imaging Analysis {#sec4.6}
---------------------------------------------------------------

Harvested lymph nodes were embedded in OCT (TissueTec), frozen and sectioned with a thickness of 10 μm on a cryostat (Leica). Sections were fixed in methanol or left unfixed, incubated with fluorescently coupled antibodies and imaged on an Axio Examiner.D1 microscope (Zeiss) equipped with LEDs of 405 nm, 488 nm, 561 nm, and 642 nm excitation wavelengths or equipped with a 4-color laser stack and a confocal spinning-disk head (Intelligent Imaging Innovations). For investigations of protein expression in HEVs, all quantifications were performed using mask analysis (Zeiss software) based on PECAM-1 expression and quantifying expression of other fluorescent channels within the mask containing PECAM+-pixels delineating HEV vascular structures as previously detailed ([@bib35]).

EAE Induction {#sec4.7}
-------------

For EAE induction the MOG35-55-CFA Emulsion PTX Kit (EK-2110, Hooke Labs) was used according to the manufacturer's protocol. Mice were anesthetized (100 mg/kg ketamine and 10 mg/kg xylazine i.p.) and bilaterally s.c. injected with 200 μg myelin oligodendrocyte glycoprotein (MOG) 35--55 in 200 μL Complete Freund's Adjuvant (CFA) at the indicated time points, followed by two i.p. injections of 200 ng pertussis toxin (PTX) in phosphate buffered saline (PBS), immediately after immunization and 24 hr later. From day 8 on, paralysis was assessed using the clinical scoring system: 0, no obvious signs of disease; 0.5, distal paralysis of the tail; 1, complete tail paralysis; 1.5, mild paresis of one or both hind legs; 2, severe paresis of both hind legs; 2.5, complete paralysis of one hind leg; 3, complete paralysis of both hind legs; 3.5, complete paralysis of hind legs and paresis of one front leg. Animals with scores of 2 and up were provided access to food and water on the bottom of the cage.

T and B Cell Isolation {#sec4.8}
----------------------

CD4^+^ T cells for Q-PCR analysis were purified from lymph nodes of C57BL/6 WT, × *S1pr1*^*+/flox*^*xCd4-cre*, *Bmal1*^*flox/flox*^x*Cd4-cre* or littermate control mice using the EasySep Mouse CD4^+^ T cell enrichment kit (StemCell Technologies). Purity was confirmed via flow cytometry and was generally \> 96%. B220^+^ B cells for western blot analysis were purified from spleens of *Bmal1*^*flox/flox*^x*Cd19-cre* or littermate control mice using the EasySep Mouse B cell enrichment kit (StemCell Technologies). The Pan T Cell Isolation Kit (Miltenyi Biotec) was used to purify total T cells from mouse splenocytes. Splenocytes were labeled with a mixture of biotin-conjugated monoclonal antibodies directed against cells other than T cells and followed by conjugate binding with anti-biotin microbeads. Magnetically labeled non-T cells were depleted with autoMACS (Miltenyi Biotec) and the negative fraction was collected, yielding an average 90% purity of (CD3^+^) T cells.

Antibodies, Western Blotting, Mass Spectrometry Analyses, Quantitative Real-Time PCR, Histology, T Cell Proliferation Analyses, *Helicobacter Pylori* Infection and Influenza A Virus Infection {#sec4.9}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Statistical Analyses {#sec4.10}
--------------------

All data are represented as mean ± SEM. Comparisons between two samples were performed using the paired and unpaired Student's t tests or Mann-Whitney test. One-way ANOVA analyses followed by Tukey's multiple comparison test, two-way ANOVA analyses followed by Bonferroni's post hoc test were used for multiple group comparisons. Statistical analyses were performed with GraphPad Prism 6 software. Statistical significance was assessed as ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, and ^∗∗∗∗^p \< 0.0001.
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Document S1. Figures S1--S6 and Supplemental Experimental ProceduresMovie S1. Schematic Movie of Circadian Lymphocyte Migration through Lymph NodesMovie showing the circadian migration of lymphocytes through lymph nodes. At night onset, increased homing due to higher amounts of lymphocyte CCR7 leads to enhanced lymphocyte counts in the lymph node. During the day, higher S1pr1 expression induces the egression of lymphocytes into efferent lymph. Related to Figure 6.Document S2. Article plus Supplemental Information
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![Lymphocyte Numbers Exhibit Circadian Oscillations in Lymph Nodes\
(A) Lymphocyte oscillations in blood (left panel) and inguinal lymph node (middle and right panels) over 24 hr. Zeitgeber time (ZT, time after light onset) 1 is double-plotted to facilitate viewing; n = 4--49 mice, one-way ANOVA, WBC: white blood cells.\
(B) Lymph node oscillations under light-dark (LD), dark-dark (DD) and inverted, dark-light (DL) conditions, normalized to peak times; CT, circadian time in constant darkness conditions; n = 3--15 mice, one-way ANOVA.\
(C) Oscillations across multiple lymph nodes, axi: axillary, sup: superficial cervical, ing: inguinal, mes: mesenteric, com: combined counts; n = 3--19 mice, one-way ANOVA, counts are plotted per single lymph node.\
(D) Lymph node counts after treatment with FTY720 (egress block) or integrin-blocking antibodies (homing block); n = 3--5 mice, one-way ANOVA with Tukey's multiple comparisons test.\
(E) Lymphocyte subpopulations after homing block (left) and egress block (right); n = 3 mice. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001. All data are represented as mean ± SEM. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Rhythmic Lymphocyte Homing Is Dependent on Oscillations in Both Lymphocytes and Microenvironment\
(A) Lymph node homing of lymphocyte populations over the course of the day, normalized to peak times; n = 3--17 mice, one-way ANOVA.\
(B) Adoptive transfer of lymphocyte populations using donor and recipient mice kept at ZT5 or ZT13; n = 6--17 mice, one-way ANOVA with Tukey's multiple comparisons test.\
(C) Oscillations of CCR7 surface expression on lymphocyte subpopulations in LN; n = 3--5 mice, one-way ANOVA.\
(D) Q-PCR analysis of LN *Ccl21* amounts over 24 hr; n = 3--5 mice, one-way ANOVA.\
(E) Quantification and images of expression of CCL21 on HEV over 24 hr in constant darkness (CT, circadian time: the corresponding light and dark phase are indicated); n = 3--18 mice, one-way ANOVA. Scale bar represents 50 μm.\
(F) LN homing of lymphocytes harvested at ZT5 or ZT13 and treated with or without pertussis toxin (PTX); n = 5--11 mice, one-way ANOVA with Tukey's multiple comparisons test.\
(G) Lack of oscillations in LN cellularity of *Ccr7*^*−/−*^ mice; n = 4 mice, unpaired Student's t test.\
(H) Lack of rhythmic LN homing of *Ccr7*^*−/−*^ cells into WT hosts; n = 5--6 mice, unpaired Student's t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001. All data are represented as mean ± SEM. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Oscillations of Circadian Clock Genes in Lymph Nodes Control Cellularity\
(A) Q-PCR analysis of circadian clock genes in LN over 24 hr; n = 3--5 mice, one-way ANOVA.\
(B) Circadian clock gene mRNA profiles in sorted CD4^+^ T cells from *Bmal1*^*flox/flox*^x*Cd4-cre* and control animals; n = 3--10 mice, two-way ANOVA.\
(C) Lymph node CD4 and CD8 T cell counts in control and T cell specific *Bmal1*^*−/−*^ mice, n = 3--9 mice, one-way and two-way ANOVA.\
(D) LN homing of lymphocytes harvested from control or T cell-specific *Bmal1*^*−/−*^ mice at ZT5 or ZT13 into WT hosts; n = 10--34 mice, one-way ANOVA with Tukey's multiple comparisons test.\
(E) CCR7 surface expression on T lymphocyte subpopulations in LN of control and T cell-specific *Bmal1*^*−/−*^ mice; n = 3--5 mice, one-way ANOVA.\
(F) Q-PCR analysis of CD4^+^ T cell *Ccr7* over 24 hr in control and T cell-specific *Bmal1*^*−/−*^ mice; n = 4--8 mice, one-way and two-way ANOVA. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001. All data are represented as mean ± SEM. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Circadian Oscillations in Lymphocyte Egress from LNs\
(A) Oscillations of total leukocyte (left panel) and lymphocyte (right panel) counts in efferent lymph over 24 hr; n = 6--33 mice, one-way ANOVA.\
(B) Lymph leukocyte count oscillations under light-dark (LD) and dark-dark (DD) conditions; n = 3--37 mice, one-way ANOVA.\
(C and D) Remaining cellular numbers (in %) in lymph node (C) and lymph (D) over 24 hr after block of leukocyte homing. Lymph node: n = 3--10 mice; lymph: n = 3--6 mice, unpaired Student's t test.\
(E) Lymph CD4^+^ and CD8^+^ T cell counts in T cell-specific *Bmal1*^*−/−*^ mice; n = 3--8 mice, one-way ANOVA.\
(F) Remaining cells (in %) in lymph nodes of adoptively transferred control and BMAL1-deficient CD4^+^ T cells 12 hr after transfer; n = 4--13, unpaired Student's t test.\
(G) Mathematical model of leukocyte homing and egress. The model is expressed as a line based on the indicated data points. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001. All data are represented as mean ± SEM. See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![Rhythmic Lymphocyte Egress Depends on Oscillatory S1pr1 Expression\
(A) Q-PCR analysis of LN *S1pr1* over 24h. n = 3--5 mice, one-way ANOVA.\
(B) Lymph counts after blockade of S1P-receptor function using FTY720 at the indicated times; n = 3--33 mice, two-way ANOVA.\
(C) FTY720 titration and respective lymph counts at two time points. n = 3--5 mice.\
(D) Q-PCR analysis of CD4^+^ T cell *S1pr1* over 24 hr in control and T cell-specific *Bmal1*^*−/−*^ mice; n = 4--9 mice, one-way and two-way ANOVA.\
(E) Normalized activity (in %) of Gaussia Luciferase driven by murine *S1pr1* promoter (*S1pr1*-GLuc) after co-transfection with various doses of *Clock* and *Bmal1* plasmids in HEK293 cells (n = 6). Data shown are pooled from two independent experiments, one-way ANOVA with Tukey's multiple comparisons test.\
(F) LN CD4^+^ and CD8^+^ T cell counts in control and T cell-specific *S1pr1* heterozygous mice; n = 3--6 mice, one-way and two-way ANOVA.\
(G) Lymph CD4^+^ and CD8^+^ T cell counts in control and T cell-specific *S1pr1* heterozygous mice; n = 3--12 mice, one-way and two-way ANOVA.\
(H) Mass spectrometric analysis of sphingosine-1-phosphate (S1P) in lymph and blood plasma; n = 9--11 mice. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001. All data are represented as mean ± SEM. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![T Cell Clock Function Regulates Disease Severity in EAE\
(A) Oscillations of CD69^+^ T cell numbers in lymph node; n = 3--5 mice, one-way ANOVA.\
(B) Oscillations of migratory dendritic cells (DCs) in lymph node; n = 6--12 mice, one-way ANOVA.\
(C) EAE disease scores of mice immunized at ZT8 or ZT20. Disease score EC~50~ comparisons show accelerated symptom progression in ZT8-immunized mice; n = 5 mice, two-way ANOVA (left panel) and unpaired Student's t test (right panel).\
(D) Quantification of demyelination in lumbar spinal cord sections; n = 5 mice, unpaired Student's t test.\
(E) Luxol Fast Blue staining of lumbar spinal cord sections of mice immunized at ZT8 (top) or ZT20 (bottom) at the peak of the disease showing demyelinated areas (arrows), scale bar represents 200 μm (left images), 100 μm (right images).\
(F) LN IL-2 mRNA after EAE induction; n = 3--5 mice, unpaired Student's t test.\
(G) LN counts of IL-17^+^ and VLA-4^+^ CD4^+^ T cells after EAE induction; n = 5 mice, unpaired Student's t test.\
(H--J) Diurnal profiles of inguinal lymph node counts of total CD4^+^ T cells (H), naive CD4^+^ T cells (I), and activated CD4^+^ T cells (J) on day 2 after EAE induction; n = 4 mice, two-way ANOVA with Bonferroni's post hoc test.\
(K) EAE disease scores and EC~50~ values in T cell-specific *Bmal1*^*−/−*^ mice immunized at ZT8 or ZT20; n = 5 mice.\
(L) Inguinal lymph node counts of CD4^+^ T cells, and CD8^+^ T cells in T cell-specific *Bmal1*^*−/−*^ mice at ZT15 on day 2 after EAE induction; n = 4--5 mice, unpaired Student's t test.\
(M) Schematic diagram of circadian lymphocyte migration through lymph nodes. At night onset, increased homing due to higher CCR7 amounts leads to enhanced lymphocyte counts in the lymph node. During the day, higher *S1pr1* expression induces the egression of lymphocytes into efferent lymph. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001. All data are represented as mean ± SEM. See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Movie S1](#mmc2){ref-type="supplementary-material"}.](gr6){#fig6}
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